Drosophila melanogaster as a model of systemic dermatophytosis

Mycoses. 2023 Oct;66(10):906-910. doi: 10.1111/myc.13630. Epub 2023 Jul 11.

Abstract

Background: Dermatophytosis is one of the most common fungal infections worldwide. The distribution of dermatophytes varies across continents, but the genera Trichophyton and Microsporum have emerged as the main isolated agents in humans and animals.

Objectives: To validate Drosophila melanogaster flies as a fast and feasible model to study dermatophytic infections.

Methods: Wild-type (WT) and Toll-deficient D. melanogaster flies were infected by Trichophyton rubrum, T. mentagrophytes, Microsporum canis and Nannizzia gypsea by pricking with a needle previously dipped in inoculum concentrations ranging from 103 to 108 colony-forming units/mL. Establishment of infection was confirmed by survival curves, histopathological analysis and fungal burden. Thereafter, flies were treated with terbinafine, itraconazole and clioquinol.

Results: WT flies were predominantly resistant to the infection, whereas Toll-deficient flies succumbed to the four dermatophyte genera tested. The antifungal drugs protected flies from the infection, except for N. gypsea whose survival curves did not differ from the untreated group.

Conclusions: This pilot study confirms that D. melanogaster is a suitable model to study the virulence and antifungal drug efficacy in dermatophyte species.

Keywords: Drosophila melanogaster; dermatophyte; systemic infection.

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Arthrodermataceae*
  • Drosophila melanogaster
  • Humans
  • Itraconazole
  • Pilot Projects
  • Tinea* / drug therapy
  • Tinea* / microbiology
  • Trichophyton

Substances

  • Antifungal Agents
  • Itraconazole